RegisterLogin

CDK-TCIP2

CAT: 0931-T201211-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-T201211-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Target
Bcl-6|||CDK
Related Pathways
Immunology/Inflammation|||Cell Cycle/Checkpoint
Bioactivity
DK-TCIP2 is an anticancer agent formed by linking the CDK9 inhibitor SNS-032 and the BCL6 inhibitor BI-3812. This compound exhibits anticancer activity both in vivo and in vitro, making it suitable for research in lymphoma.
Smiles
C(F)(F)(F)C1=C2C(CN(C[C@H]3C[C@@H](C(F)(F)F)CCC3)C2=O)=NC(N)=N1
Molecular Formula
C52H67ClN12O8S2
Molecular Weight
1087.75
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T201343-01CDK-TCIP1
T75127-01CDK-IN-12
T201193-01CDK-IN-15
T36741-01CDK-IN-6
T62235-01CDK-IN-9
T60869-01CDK-IN-10
TQ0078-01CDK-IN-2
T84917-01CDK-IN-11
T208739-01CDK-IN-13
T204162-01CDK-IN-16

Alternative Products

CatalogName
HY-169245-01CDK-TCIP2
MBS5804923CDK-IN-9
BUP12701-01CDK-IN-2
HY-147386-01CDK-IN-10
HY-170507CDK-IN-16
HY-168067CDK-IN-14
MBS5797812-01CDK-IN-6
MBS5817050CDK-IN-12
HY-201330CDK-IN-18
HY-149173-01CDK-IN-11

Popular Products